An interventional study of Face-to-face nutrition education and Intermittent Fasting Diet in Hypertension, sponsored by Nadide Gizem Tarakci Filiz. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 40 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-09-25.
Sponsored by Nadide Gizem Tarakci Filiz · Not applicable, Interventional, and Treatment
Hypertension (HT) is an important risk factor for cardiovascular diseases (CVD) and death. Approximately 16.9 million people in Turkey have HT. Nutritional habits play an important role in the development of HT. DASH (Dietary Approaches to Stop Hypertension) and the Mediterranean diet (MD) have been found to be effective in lowering blood pressure and reducing cardiometabolic risks. The DASH diet stands out with its low sodium, saturated fat, simple sugar and cholesterol content, while it is rich in fiber, potassium, magnesium and anti-inflammatory components. The MD is based on healthy foods such as olive oil, vegetables, fruits, fish and nuts, and contains antioxidants and healthy fatty acids. This study will investigate whether the sodium-restricted MD can offer a model comparable to DASH. In addition, the effects of the intermittent fasting diet (IFD) model alone and in combination with the MD on blood pressure will be examined. It has been observed that IFD reduces blood pressure by reducing energy intake and acting on the autonomic nervous system. The aim of this project is to evaluate the effects of MD, IFD and both of them on hypertension and to present a new and original approach in this field.
6,114 studies on the registry are indexed under Hypertension; 912 are open to participants now.
This study's planned enrollment of 48 is below the median of 100 across 4,575 interventional studies indexed under Hypertension.
Browse Hypertension studies →Nadide Gizem Tarakci Filiz is the lead sponsor of 2 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants will be excluded if they have any of the following:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will only receive face-to-face nutrition education.
Other: Face-to-face nutrition education
Participants will receive face-to-face nutrition education and Intermittent Fasting Diet. Additionally, a brochure package containing information about Intermittent Fasting Diet models will be prepared by a dietitian and distributed to participants by the same dietitian along with the training.
Other: Face-to-face nutrition education · Other: Intermittent Fasting Diet
Participants will receive face-to-face nutrition education and Mediterranean Diet. Additionally, a brochure package containing information about Mediterranean Diet models will be prepared by a dietitian and distributed to participants by the same dietitian along with the training. Three separate packages compliant with the Mediterranean Diet will be given at the start of the study, 2nd week and 4th week. Package 1: 250 mL natural extra virgin olive oil, 150 g walnuts, 1 avocado, 250 g black raisins, 1 L semi-skimmed UHT cow's milk, 1 kg green lentils and 1 garlic clove Package 2: 250 mL of natural extra virgin olive oil, 200 g of raw hazelnuts, 150-200 g of unsalted black olives, 140 g of dried apricots, 1 L of semi-skimmed UHT cow's milk, 1 kg of dried beans, and 700 g of unsalted tomato paste Package 3: 250 mL extra virgin olive oil, 180 g unsalted pumpkin seeds, 1 kg apples, 1 L semi-skimmed UHT cow's milk, 500 g whole wheat pasta and 500 g red lentils
Other: Face-to-face nutrition education · Other: Mediterranean Diet
Participants will receive face-to-face nutrition education and the combination of IFD and MD. Additionally, a brochure package containing information about IFD and MD models will be prepared by a dietitian and distributed to participants by the same dietitian along with the training. Three separate packages compliant with the MD will be given at the start of the study, 2nd week and 4th week. Pkg. 1: 250 mL natural extra virgin olive oil, 150 g walnuts, 1 avocado, 250 g black raisins, 1 L semi-skimmed UHT cow's milk, 1 kg green lentils and 1 garlic clove Pkg. 2: 250 mL of natural extra virgin olive oil, 200 g of raw hazelnuts, 150-200 g of unsalted black olives, 140 g of dried apricots, 1 L of semi-skimmed UHT cow's milk, 1 kg of dried beans, and 700 g of unsalted tomato paste Pkg. 3: 250 mL extra virgin olive oil, 180 g unsalted pumpkin seeds, 1 kg apples, 1 L semi-skimmed UHT cow's milk, 500 g whole wheat pasta and 500 g red lentils
Other: Face-to-face nutrition education · Other: Intermittent Fasting Diet · Other: Mediterranean Diet
All participants will receive face-to-face nutrition education from specialist dietitians in accordance with the principles of nutrition for hypertension. Nutrition education will be provided through prepared brochures. The brochures will be given to participants as gifts. Nutrition education will cover topics such as hypertension and nutrition, nutrients, the importance of micronutrients, foods containing salt, reading labels, limiting salt consumption, healthy fat consumption, fibre consumption, water consumption, and healthy cooking methods.
Training will be provided to all participants through a food and nutrition photo catalogue so that portions can be recorded correctly and within standard limits when keeping a food diary. Participants will restrict their food intake to a 16-hour period by applying the 16/8 Intermittent Fasting Diet model and will eat and drink whatever they want during the remaining 8 hours. During this 16-hour period, they will consume non-energy drinks consisting of water, unsweetened tea, unsweetened herbal teas and black coffee. It will be recommended that intermittent fasting be maintained from 6:00 p.m. to 10:00 a.m. However, participants may also choose other 16-hour periods, such as 7:00 p.m. to 11:00 a.m. or 8:00 p.m. to 12:00 p.m. Participants will be given a tracking chart to record the first and last times they consume food or energy-containing beverages during the day, and their adherence to the diet will be monitored based on their declarations.
Training will be provided to all participants through a food and nutrition photo catalogue to ensure that portions are recorded correctly and within standard limits when keeping a food diary. In addition, the dietician will provide this group with a diet plan calculated for energy, macro and micro nutrients, which will be different each week for the first four follow-ups. The diet plans provided will be prepared in accordance with the Mediterranean Diet food pyramid. Participants' energy requirements will be calculated using the Schofield Equation for basal metabolic rate, with adjustments made according to their physical activity levels. Energy requirements will be met by 45-50% from carbohydrates, 15-20% from protein, and 25-35% from fats.
Blood pressure
The participants' blood pressure will be measured six times in this research. Blood pressure measurements will be taken by a trained physician in accordance with standard measurement protocols. Measurements will be taken after a 5-minute rest period, with the patient seated, using an automatic blood pressure monitor with the correct cuff size applied to the arm. Two consecutive measurements will be taken for each patient, with at least 1 minute between measurements. The average of the two measurements obtained will be used in the analyses. The following points will be taken into consideration during the measurements. * Patients should not have smoked, consumed caffeine, or exercised in the last 30 minutes * During the measurement, the patient should be leaning back with their feet flat on the floor * The arm being measured should be supported at heart level Blood pressure values will be evaluated according to the 2023 ESC/ESH hypertension guidelines.
Time frame: At enrollment, 1 week later than enrollment, 2 weeks later than enrollment, 3 weeks later than enrollment, 4 weeks later than enrollment, 13 weeks later than enrollment, 26 weeks later than enrollment
Height in cm
Height measurement will be taken by a specialist dietician. It will be performed in accordance with the measurement techniques and standards recommended by the International Society for the Advancement of Kinanthropometry. Participants' heights will be measured barefoot using a stadiometer with an accuracy of 0.01 m.
Time frame: At enrollment, 1 week later than enrollment, 2 weeks later than enrollment, 3 weeks later than enrollment, 4 weeks later than enrollment, 13 weeks later than enrollment, 26 weeks later than enrollment
Body weight in kg
Body weight measurement will be taken by a specialist dietician. It will be performed in accordance with the measurement techniques and standards recommended by the International Society for the Advancement of Kinanthropometry. Body weight and body composition will be measured using a body composition analyser with a precision of 0.1 kg. The participants' clothing weight (1.0 kg) will be recorded on the analyser before measurement. Measurements will be taken barefoot and with participants wearing light clothing. Metal objects on participants will be removed.
Time frame: At enrollment, 1 week later than enrollment, 2 weeks later than enrollment, 3 weeks later than enrollment, 4 weeks later than enrollment, 13 weeks later than enrollment, 26 weeks later than enrollment
Body Mass Index (BMI) in kg/m²
Body Mass Index (BMI) will be used to assess whether an individual's body weight is appropriate for their height. It is calculated by dividing a person's body weight, measured in kilograms (kg), by the square of their height, measured in meters (m). Since height will be measured in centimeters (cm), it will first be converted into meters. This will be done by dividing the height in centimeters by 100.
Time frame: At enrollment, 1 week later than enrollment, 2 weeks later than enrollment, 3 weeks later than enrollment, 4 weeks later than enrollment, 13 weeks later than enrollment, 26 weeks later than enrollment
Waist circumference in cm
Waist circumference: Waist circumference will be taken by a specialist dietician. It will be measured at the narrowest point of the waist with the individual standing upright and without any clothing around the waist. Measurements will be taken with a tape measure, ensuring it is in contact with the skin without applying excessive pressure.
Time frame: At enrollment, 1 week later than enrollment, 2 weeks later than enrollment, 3 weeks later than enrollment, 4 weeks later than enrollment, 13 weeks later than enrollment, 26 weeks later than enrollment
Fasting plasma glucose in mg/dL
This will be obtained from blood tests. Reference values: 70-99 mg/dL
Time frame: At enrollment, 13 weeks later than enrollment, 26 weeks later than enrollment
HbA1c in %
This will be obtained from blood tests. Reference values: \< 5.7% (normal), 5.7-6.4% (prediabetes), ≥ 6.5% (diabetes)
Time frame: At enrollment, 13 weeks later than enrollment, 26 weeks later than enrollment
Insulin in µU/mL
This will be obtained from blood tests. Reference values: 2-25 µU/mL
Time frame: At enrollment, 13 weeks later than enrollment, 26 weeks later than enrollment
Triglycerides in mg/dL
This will be obtained from blood tests. Reference values: \< 150 mg/dL
Time frame: At enrollment, 13 weeks later than enrollment, 26 weeks later than enrollment
HDL cholesterol in mg/dL
This will be obtained from blood tests. Reference values: Men: ≥ 40 mg/dL Women: ≥ 50 mg/dL
Time frame: At enrollment, 13 weeks later than enrollment, 26 weeks later than enrollment
LDL cholesterol in mg/dL
This will be obtained from blood tests. Reference values: \< 100 mg/dL
Time frame: At enrollment, 13 weeks later than enrollment, 26 weeks later than enrollment
Total cholesterol in mg/dL
This will be obtained from blood tests. Reference values: \< 200 mg/dL
Time frame: At enrollment, 13 weeks later than enrollment, 26 weeks later than enrollment
Urea in mg/dL
This will be obtained from blood tests. Reference values: 7-20 mg/dL
Time frame: At enrollment, 13 weeks later than enrollment, 26 weeks later than enrollment
Creatinine in mg/dL
This will be obtained from blood tests. Reference values: Men: 0.7-1.3 mg/dL Women: 0.6-1.1 mg/dL
Time frame: At enrollment, 13 weeks later than enrollment, 26 weeks later than enrollment
Sodium in mmol/L
This will be obtained from blood tests. Reference values: 135-145 mmol/L
Time frame: At enrollment, 13 weeks later than enrollment, 26 weeks later than enrollment
Potassium in mmol/L
This will be obtained from blood tests. Reference values: 3.5-5.0 mmol/L
Time frame: At enrollment, 13 weeks later than enrollment, 26 weeks later than enrollment
hs-CRP in mg/L
This will be obtained from blood tests. Reference values: \< 1 mg/L (low cardiovascular risk), 1-3 mg/L (intermediate risk), \> 3 mg/L (high risk)
Time frame: At enrollment, 13 weeks later than enrollment, 26 weeks later than enrollment
ALT in U/L
This will be obtained from blood tests. Reference values: Men: \< 41 U/L; Women: \< 31 U/L
Time frame: At enrollment, 13 weeks later than enrollment, 26 weeks later than enrollment
AST in U/L
This will be obtained from blood tests. Reference values: Men: \< 40 U/L; Women: \< 32 U/L
Time frame: At enrollment, 13 weeks later than enrollment, 26 weeks later than enrollment
GGT in U/L
This will be obtained from blood tests. Reference values: Men: 8-61 U/L; Women: 5-36 U/L
Time frame: At enrollment, 13 weeks later than enrollment, 26 weeks later than enrollment
Plan to share: Yes
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nadide Gizem Tarakci Filiz